Literature DB >> 28163102

The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5.

S Guaita-Esteruelas1, J Gumà2, L Masana3, J Borràs2.   

Abstract

The adipose tissue microenvironment plays a key role in tumour initiation and progression because it provides fatty acids and adipokines to tumour cells. The fatty acid-binding protein (FABP) family is a group of small proteins that act as intracellular fatty acid transporters. Adipose-derived FABPs include FABP4 and FABP5. Both have an important role in lipid-related metabolic processes and overexpressed in many cancers, such as breast, prostate, colorectal and ovarian. Moreover, their expression in peritumoural adipose tissue is deregulated, and their circulating levels are upregulated in some tumours. In this review, we discuss the role of the peritumoural adipose tissue and the related adipokines FABP4 and FABP5 in cancer initiation and progression and the possible pathways implicated in these processes.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipose tissue; Cancer associated adipocytes; FABP4; FABP5; Lipid metabolism

Mesh:

Substances:

Year:  2017        PMID: 28163102     DOI: 10.1016/j.mce.2017.02.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  28 in total

1.  Conventional Nanosized Drug Delivery Systems for Cancer Applications.

Authors:  Cristian Vergallo; Muhammad Nadeem Hafeez; Dalila Iannotta; Hélder A Santos; Nicola D'Avanzo; Luciana Dini; Felisa Cilurzo; Massimo Fresta; Luisa Di Marzio; Celia Christian
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.

Authors:  Sanjukta Chakraborty; Michelle Carnazza; Tara Jarboe; Nicole DeSouza; Xiu-Min Li; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Lipid metabolism in tumor microenvironment: novel therapeutic targets.

Authors:  Xingkai Liu; Ping Zhang; Jing Xu; Guoyue Lv; Yan Li
Journal:  Cancer Cell Int       Date:  2022-07-05       Impact factor: 6.429

Review 4.  Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential.

Authors:  Yuhao Zhou; Yuan Zhan; Weiling Jiang; Huiguo Liu; Shuang Wei
Journal:  Oxid Med Cell Longev       Date:  2022-06-15       Impact factor: 7.310

Review 5.  Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer.

Authors:  Cristina Aguirre-Portolés; Lara P Fernández; Ana Ramírez de Molina
Journal:  Nutrients       Date:  2017-09-28       Impact factor: 5.717

Review 6.  Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.

Authors:  Seema Gupta; Amrita Roy; Bilikere S Dwarakanath
Journal:  Front Oncol       Date:  2017-04-12       Impact factor: 6.244

7.  The natural compound GL22, isolated from Ganoderma mushrooms, suppresses tumor growth by altering lipid metabolism and triggering cell death.

Authors:  Ge Liu; Kai Wang; Shan Kuang; Ruobing Cao; Li Bao; Rui Liu; Hongwei Liu; Chaomin Sun
Journal:  Cell Death Dis       Date:  2018-06-07       Impact factor: 8.469

Review 8.  Adipose Tissue Metabolism and Cancer Progression: Novel Insights from Gut Microbiota?

Authors:  Benedicte F Jordan; Florian Gourgue; Patrice D Cani
Journal:  Curr Pathobiol Rep       Date:  2017-10-24

Review 9.  Revisiting ovarian cancer microenvironment: a friend or a foe?

Authors:  Boyi Zhang; Fei Chen; Qixia Xu; Liu Han; Jiaqian Xu; Libin Gao; Xiaochen Sun; Yiwen Li; Yan Li; Min Qian; Yu Sun
Journal:  Protein Cell       Date:  2017-09-19       Impact factor: 14.870

Review 10.  FABP5 as a novel molecular target in prostate cancer.

Authors:  Saoirse Elizabeth O'Sullivan; Martin Kaczocha
Journal:  Drug Discov Today       Date:  2020-09-20       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.